Acasti Pharma (ACST) Swings to Q3 Profit

Acasti Pharma (NASDAQ: ACST) reported Q3 EPS of $0.03, versus ($0.05) reported last year. Revenue for the quarter came in at $29 million, versus $28 million reported last year.

For earnings history and earnings-related data on Acasti Pharma (ACST) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c